Contract Pharmaceuticals Limited

Penn Pharma, a PCI company, has over 35 years of experience in providing integrated drug development, clinical trial supply, manufacturing and packaging services to the international healthcare industry.

With a full range of contract services available Penn is able to take compounds from the earliest stages of development through to commercialisation. It is this “molecule to market” offering from Penn that ensures true speed to market for our global client base.

Recognised for our regulatory and export experience, Penn supplies many markets including Europe, the USA, South America and Japan. Our Knowledge and expertise, has enabled us to become the trusted partner for many of the world’s top pharmaceutical companies.

In recent years, we have invested to expand our operations including a purpose-built contained manufacturing facility which opened in 2013 followed by a large-scale commercial manufacturing suite which became operational in 2014. With this significant expansion programme, we are now able to offer over 0.5 billion doses of capacity on site ranging from 1kg to 300kg scale for non-potent and 1kg to 120kg scale for potent molecules.

Penn's facilities meet the highest quality and regulatory standards, are licensed by the MHRA and inspected by the FDA. Penn is also licensed by the UK Home Office for importation and storage of controlled drugs.

Core services include:
Formulation development, Analytical development & stability, Clinical trial supply, Manufacturing - Clinical/Commercial/Contained, including highly potent molecules, from pilot to commercial batch sizes, Manufacture of specials (unlicensed medicines), Supply chain management - including the storage, distribution, returns, destruction and inventory management of clinical trial material, QA services, Qualified Person (QP) Release.
Dosage forms include; Solid - tablets, capsules, granules, powders, Semi solid - creams, ointment & gels, Liquids - solutions & suspensions.

A&A Pharmachem Inc. (founded 1992) is a leading Canadian supplier and distributor of:

- Pharmaceutical ingredients and regulatory compliance solutions
- Over the Counter ingredients products and ingredients
- Nutraceutical Ingredients
- Sports Nutrition Ingredients
- Food Ingredients

In the Pharmaceutical sector we represent many active pharmaceutical ingredient (API) manufacturers from India, China, and Taiwan as well as Western and Eastern Europe.

In the past 23 years, we have developed strong relationships with manufacturers of raw materials from Europe, India, China, US, South America, Japan. We can source and provide hard to find ingredients at cost effective prices. We differentiate from others by emphasizing on professional service and quality products, and by focusing on value creation for our customers.

Our portfolio of high quality Nutraceuticals Ingredients consists of Botanical Extracts and Powders, Specialty Ingredients, Amino Acids and Derivatives, Minerals, Vitamins, Sweeteners, Proteins, Enzymes and Blends, Vitamins and Blends, Excipients, Essential and Carrier Oils. We also stock substantial quantities of Whey Protein Concentrate, Whey Protein Isolate, Creatine Monohydrate, L-Glutamine and Branched Chain Amino Acids. In addition to the products listed on our site, we can source a wide range of specialized materials and formulations through our international network of suppliers. We act as a one stop shop by providing non-ingredient sourcing solutions such as packaging items, ranging from HDPE and PET packers and jars, to liquid and powder flavours.

Our distribution network covers entire North America through a network of 8 warehouses in Quebec, Ontario, Manitoba, British Columbia, New Jersey, Denver and Chicago. Our distributed operations enable us to deliver smallest to the largest orders efficiently and cost effectively.

Acino, a Swiss pharmaceutical company headquartered in Zurich, develops, manufactures and internationally markets well-proven and innovative pharmaceuticals in novel drug delivery forms. Under the brand ‘Acino Switzerland’, Acino sells high-quality medicines in emerging markets with a strategic focus on the Middle East, Africa, Ukraine/CIS including Russia, and Latin America.

Acino is a leader in advanced drug delivery technologies specializing in modified release oral forms and oral dispersible forms, for which it also holds patents. As a partner of pharmaceutical companies worldwide, Acino supplies finished in-house developed products and/or provides customized one-stop solutions from product development and registration to contract manufacturing, packaging and logistics.

Please find more information on our website acino.swiss

Dow combines global breadth, asset integration and scale, focused innovation, and leading business positions to achieve profitable growth. Our ambition is to become the most innovative, customer-centric, inclusive, and sustainable materials science company, with a purpose to deliver a sustainable future for the world through our materials science expertise and collaboration with our partners. Our portfolio of plastics, industrial intermediates, coatings and silicones businesses delivers a broad range of differentiated science-based products and solutions for its customers in high-growth market segments, such as packaging, infrastructure, mobility, and consumer care. We operate 106 manufacturing sites in 31 countries and employ approximately 35,700 people.

Own products (APIs) for the generic pharmaceutical industry.

We provide quality products and services, consistently,
reliably responsibly and continuously applying some of the world’s
most difficult to handle chemical technologies.
Our independent one-site,
single entity corporate setup enables


Synthesis: Manufacturing services and products for all user industries,
using Archimica´s highly differentiated setup and technologies
APIs, Building blocks, GMP intermediates, Regulatory Starting Materials
For all global markets including the United States of America,
in total Archimica products reach 25 countries.